APA (7th ed.) Citation

MS, O., A, G., DA, W., NA, M., YK, C., A, B., & VM, V. (2021). The Impact of Beta Blockers on Survival Outcomes in Patients With Non-small-cell Lung Cancer Treated With Immune Checkpoint Inhibitors. Clinical lung cancer, 22(1), e57. https://doi.org/10.1016/j.cllc.2020.07.016

Chicago Style (17th ed.) Citation

MS, Oh, Guzner A, Wainwright DA, Mohindra NA, Chae YK, Behdad A, and Villaflor VM. "The Impact of Beta Blockers on Survival Outcomes in Patients With Non-small-cell Lung Cancer Treated With Immune Checkpoint Inhibitors." Clinical Lung Cancer 22, no. 1 (2021): e57. https://doi.org/10.1016/j.cllc.2020.07.016.

MLA (9th ed.) Citation

MS, Oh, et al. "The Impact of Beta Blockers on Survival Outcomes in Patients With Non-small-cell Lung Cancer Treated With Immune Checkpoint Inhibitors." Clinical Lung Cancer, vol. 22, no. 1, 2021, p. e57, https://doi.org/10.1016/j.cllc.2020.07.016.